Results for intra tumoral mast cells translation from English to Slovenian

mast cells
tkivni bazofilec

mast cell tumours are cancerous proliferations of mast cells.
tumorji mastocitov so rakava oblika rasti in razmnoževanja mastocitov.

or mediators from skin mast cells, basophils and eosinophils.
in vitro je takrolimus v langerhansovih celicah, izoliranih iz normalne človeške kože, zmanjšal stimulacijsko delovanje na celice t.

mast cell
tkivni bazofilec

tacrolimus has also been shown to inhibit the release of inflammatory mediators from skin mast cells, basophils and eosinophils.
dokazano je tudi, da takrolimus zavre sproščanje mediatorjev vnetja zd

data from in vitro studies suggest that it may act on human conjunctival mast cells to inhibit the release of pro-inflammatory mediators.
podatki iz študij in vitro kažejo, da lahko deluje na človeške mastocite v veznici in zavira sproščanje vnetnih mediatorjev.

increased cyclic amp levels cause relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.
zvišanje ravni cikličnega amp povzroči sprostitev bronhialnih gladkih mišic in zavre sproščanje mediatorjev takojšnje preobčutljivosti iz celic, predvsem iz mastocitov.

some types of mast-cell tumour are linked to a mutation that causes excessive action of c-kit and stimulates the mast cells to divide uncontrollably.
nekatere vrste mastocitomov so povezane z mutacijo, ki povzroča čezmerno delovanje beljakovine c-kit in spodbuja mastocite k nenadzorovanemu razmnoževanju.

these enzymes can be found in mast- cell tumours, where they are involved in the growth and spread of cancer cells, and the growth of blood vessels.
ti encimi se nahajajo v mastocitnih tumorjih, kjer sodelujejo pri rasti in širjenju rakavih celic in rasti krvnih žil.

masivet is a prescription medicine used to treat dog mast cell tumours.
masivet je zdravilo na recept, namenjeno za zdravljenje tumorjev mastocitov pri psih.

in certain circumstances, mast cell tumours can be life threatening for your dog.
v določenih okoliščinah so lahko tumorji mastocitov za vašega psa smrtno nevarni.

there was no evidence of an anaphylactic response due to mast-cell degranulation in cynomolgus monkeys.
pri opicah cinomolgus ni bilo znakov anafilaktičnega odziva zaradi degranulacije mastocitov.

it must not be used in patients who have a disease that is causing bleeding, such as stomach ulcer or bleeding in the brain or in patients with mastocytosis (high blood levels of certain white blood cells called mast cells).
ne sme se uporabljati pri bolnikih z obolenji, ki povzročajo krvavitve, kot so želodčne razjede ali možganska krvavitev, ali pri bolnikih z mastocitozo (visokimi ravnmi določenih belih krvničk, imenovanih mastociti).

if gastrointestinal ulceration is suspected, whether or not due to palladia or to mast cell tumour degranulation, stop the administration of palladia and treat appropriately.
Če sumite na gastrointestinalne ulkuse, zaradi zdravila palladia ali degranulacije mastocitoma, prekinite zdravljenje z zdravilom palladia in zdravite kot je primerno.

masivet is used to treat dogs with mast-cell tumours (a type of cancer).
zdravilo masivet se uporablja za zdravljenje psov z mastocitomi (vrsta raka).

treatment of non-resectable dog mast cell tumours (grade 2 or 3) with confirmed mutated c-kit tyrosine kinase receptor.
zdravljenje neodstranljivih tumorjev mastocitov (stopnje 2 ali 3) s potrjeno mutacijo receptorja c-kit tirozin kinaze.